Malaysian Market Community

从2026财年上半年（截至2025年12月31日）业绩表现来看，Sorento Capital 的整体财务状况展现出盈利质量改善与营运效率提升的迹象。集团于1HFY26录得营业额 RM91.3 million，较去年同期 RM94.8 million 略为下滑，主要受到经销商渠道与项目销售贡献转弱所影响。在当前房地产与装修市场节奏趋于理性的背景下，收入轻微回调属于可理解范围。 更值得关注的是盈利层面的表现。期内税前盈利按年增长30.4%至 RM22.3 million，净利润则增长39.2%至 RM16.7 million。盈利提升主要源自成本结构优化、费用管控改善，以及去年同期一次性上市费用不再出现。在收入未显著增长的情况下实现利润扩张，反映公司在营运杠杆与成本纪律方面已有明显进步，盈利质量较前期更为扎实。 业务结构方面，经销与项目销售仍为核心收入来源，合计占总营收约99.3%，线上销售占比相对较低。当前模式以渠道覆盖与品牌组合为基础，旗下拥有自有品牌并代理国际品牌，在中高端市场具备一定定位优势。管理层亦透露将拓展水喉及配件产品，进军“更换市场”，此举有助于减少对新项目交付周期的依赖，并提高日常维修与翻新需求所带来的经常性收入比重。 资产负债表方面，公司维持净现金地位，截至2025年12月31日持有 RM48.0 million 现金及现金等价物，仅有 RM3.5 million 借款。同时，集团在期内录得 RM24.8 million 正向营运现金流，显示盈利具备现金支持。公司亦正式确立不少于30%净利的派息政策，在资本结构稳健的前提下，为股东回酬提供一定保障。 综合来看，Sorento 目前处于从规模扩张转向效率优化的阶段。短期营收增长仍需观察行业需求恢复情况，但在盈利能力改善、现金充裕及派息政策明确的背景下，公司基本面稳定度正在提升。后续关键变量，将在于新产品线拓展的市场接受度，以及区域市场（包括南马及新加坡）的渗透进展。Read more

Hotel REIT valuation: Considering a spin-off of the hotel division, here's an assessment. Hotel profit has taken over the property development division.Read more

Automotive technology grows, develops and innovates-Betamek (KLSE: 0263) Catalysts 1. Betamek (KLSE: 0263) operates in the electronics manufacturing services for automotive markets in Malaysia where vehicle sales were up 6.6% 1H24.Read more

What once began as an ambitious vision to build Malaysia’s first true digital city has now taken a bold and tangible step forward. With the opening of the AI World Experience Centre at i-City, I-Berhad has transformed artificial intelligence from a future concept into a living, breathing reality—one that the public can see, touch, and interact with.Read more

Cape EMS Berhad has spent the past 18 months navigating one of the most challenging periods in its corporate history. A combination of earnings disappointments, sector-wide softness in electronics manufacturing services, and forced selling linked to margin calls on management shares pushed the stock down more than 70% from its peak above RM1.00.Read more

One quarter after the Paradigm REIT listing WCT’s balance-sheet will show the three malls (RM 2.4 bn) removed from investment properties, gross debt cut by about RM 1.3 bn and cash bolstered by the same amount before being used to repay loans, taking net debt from RM 2.0 bn to roughly RM 0.7 bn and leaving the group in a net-cash position with gearing close to zero; equity book value per share stays at RM 2.11 because the transfer is at carrying amount. The income statement will lose the malls’ rental stream (about RM 270 m revenue and RM 29 m EBITDA annually), but finance cost drops by roughly RM 60 m a year, so quarterly EBITDA falls by RM 7 m while interest expense falls by RM 15 m, leaving net profit slightly positive versus the prior run-rate; the next quarterly report will therefore show lower top-line, much lower debt, higher interest cover and a small uplift in recurring EPS.Read more

Yoong Onn Corporation Berhad (KLSE:YOCB , Ticker 5159) In the context of fluctuating consumer spending and changing retail trends, Yoong Onn Corporation Berhad (KLSE: YOCB) is establishing itself as a resilient entity in Malaysia’s home textiles sector. The company is currently trading at a significant discount compared to analyst fair value, providing potential investors with the opportunity for long-term capital growth, solid margins, and an increasing dividend yield.Read more

Duopharma Biotech Bhd (KLSE: DPHARMA, ticker 7148) Healthcare – Pharmaceuticals / Biotech Investment Review Recommendation: HOLD (Initiated) Key Metrics Company Overview Duopharma Biotech Bhd is a leading pharmaceutical manufacturer in Malaysia, involved in the research, development, manufacturing, and distribution of generic and specialty pharmaceutical products. Its operations span: Ethical Classic : General therapeutic generics (e.g., cardiovascular, anti-infectives) Ethical Specialty : Bio-similars for oncology, renal, and metabolic diseases Consumer Healthcare (CHC) : Notable OTC brands like Champs, Flavettes, and Uphamol As of 2025, it exports to multiple countries and operates from 3 GMP-certified manufacturing facilities.Read more

Infoline Tec Group Berhad (KLSE: INFOTEC, Ticker: 0253) This report presents a technical and equity analysis of Infoline Tec Group Berhad (KLSE: INFOTEC) , an IT infrastructure and cybersecurity solutions provider listed on the Main Market of Bursa Malaysia. Drawing on publicly available financials, analyst forecasts, and peer comparisons, the report examines Infoline’s operational performance, earnings profile, valuation multiples, and positioning within the Malaysian technology sector.Read more